Verax Biomedical Incorporated Revenue and Competitors
Estimated Revenue & Valuation
- Verax Biomedical Incorporated's estimated annual revenue is currently $2.1M per year.
- Verax Biomedical Incorporated's estimated revenue per employee is $77,500
- Verax Biomedical Incorporated's total funding is $64.8M.
Employee Data
- Verax Biomedical Incorporated has 27 Employees.
- Verax Biomedical Incorporated grew their employee count by -13% last year.
Verax Biomedical Incorporated Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Verax Biomedical Incorporated?
Verax Biomedical is a privately held medical products company, founded in 1999 with the vision of developing proprietary bacterial testing techniques intended to address key unmet medical and safety needs. The Company’s laboratory facilities are in Worcester, Massachusetts, just west of Boston. This location provides an ideal setting for biomedical development. Massachusetts offers an unsurpassed infrastructure, supportive biomedical community and access to a skilled workforce as well as centers of clinical and academic excellence.
keywords:N/A
$64.8M
Total Funding
27
Number of Employees
$2.1M
Revenue (est)
-13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Verax Biomedical Incorporated's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Sr. VP Operations | Reveal Email/Phone |
3 | VP | Reveal Email/Phone |
4 | VP, Research and Development | Reveal Email/Phone |
5 | SVP, Research & Development | Reveal Email/Phone |
6 | Director, Assay Development | Reveal Email/Phone |
7 | SVP and Chief Medical Officer | Reveal Email/Phone |
8 | Chief Marketing & Business Development Officer | Reveal Email/Phone |
9 | Senior Area Sales Director, West | Reveal Email/Phone |
10 | Office Manager | Reveal Email/Phone |
Verax Biomedical Incorporated News
Akin Gump Strauss Hauer & Feld: Verax Biomedical Inc. ... Carmen Group Incorporated: Koch Companies Public Sector, LLC
Congaree River Group LLC: Wejo Data Services, Incorporated ... Akin Gump Strauss Hauer & Feld: Verax Biomedical Inc.
Funding supports ongoing commercialization of Platelet PGD® Test; positions company for significant expansion and market growth in 2014 MARLBOROUGH, Mass.–(BUSINESS WIRE)–October 9, 2013– Signaling its intent to capitalize on the opportunity for its Platelet PGD® test for the detection of bact ...
Among Verax Biomedical’s investors are Village Ventures and KB Partners. The company points points out that the risk of bacterial contamination in red blood cells is lower than in platelets but it is far higher than the risk of contracting associated with transmitting viruses such as HIV, Hepat ...
Solution/product: Its Pan Genera Detection technology is aimed at detecting bacterial contamination in cells and tissues for blood transfusions and transplantations. Its Platelet PGD Test is the only test approved by the US Food and Drug Administration to detect bacterial contamination in platel ...
Other Companies in Marlborough
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $3.2M | 28 | 8% | N/A |
#2 | $2.8M | 28 | -18% | N/A |
#3 | $2.8M | 28 | 4% | N/A |
#4 | $4.8M | 28 | 8% | N/A |
#5 | $6.6M | 29 | -9% | N/A |
Verax Biomedical Incorporated Executives
| Name | Title |
|---|---|
| James Lousararian | CEO |
| Paul Mintz | svp/ Chief Medical Officer |
| Joe Sanders | Chief Marketing & Business Development Officer |
| Robert Pomorski | Vice President of Sales |
| Paul Mintz | svp/ Chief Medical Officer |
| Scott Mckenzie | Sr. VP Operations |
| Paul Ragusa | Vice President |
| Elizabeth Krodel | VP, Research and Development |
| Yli Vallejo | Senior Vice President, Research & Development |